Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
IBD Biomarker Unknowns Complicate TreatmentWith no way to predict which patient with inflammatory bowel disease will respond to which drug, clinicians often have to
use trial and error as a strategy.
Medscape Medical News, Dec 17, 2019
Patients With IBD Prone to Irritable Bowel SyndromePatients in remission from inflammatory bowel disease are susceptible to irritable bowel syndrome, but diet, cognitive therapy,
and medication can help treat the symptoms.
Medscape Medical News, Dec 16, 2019
Biosimilar for Crohn's Noninferior to AdalimumabA patent dispute means that the marketing of a biosimilar for patients with inflammatory bowel disease will be delayed, despite
approval by the US Food and Drug Administration, investigators report.
Medscape Medical News, Dec 14, 2019
Emerging Treatment Options for Crohn'sDrug therapies and the postoperative management of patients will be in the spotlight at the upcoming Advances in Inflammatory
Bowel Diseases conference.
